Skip to main content
HR 5202 115th Congress House Crime and Law Enforcement Congressional oversight Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Government studies and investigations Health personnel

Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

Introduced: March 15, 2018 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 8 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 9, 2018
Ordered to be Reported by Voice Vote.
May 9, 2018
Committee Consideration and Mark-up Session Held.
Apr 25, 2018
Forwarded by Subcommittee to Full Committee by Voice Vote .
Apr 25, 2018
Subcommittee Consideration and Mark-up Session Held.
Apr 6, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Mar 9, 2018
Referred to the Subcommittee on Health.
Mar 7, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 7, 2018
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump.

The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.

What's happening now May 9, 2018

Ordered to be Reported by Voice Vote.

 Related & companion bills 2
  • S 2680 Related bill Opioid Crisis Response Act of 2018
  • S 916 Related bill Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 6
All 6 Republican 4
R
Tenney, Claudia
New York · Jun 12, 2018
WALDEN, GREG
· May 22, 2018
 R
Blackburn, Marsha
Tennessee · May 9, 2018
 R
Rouzer, David
North Carolina · Mar 22, 2018
Handel, Karen
· Mar 15, 2018
 R
Stefanik, Elise M.
New York · Mar 15, 2018
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5202: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-5202/
MLA
"H.R. 5202: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-5202/.
Bluebook (legal)
H.R. 5202, 115th Cong. (2026), https://openamerica.io/bill/115-HR-5202/.
Markdown link
[H.R. 5202: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018](https://openamerica.io/bill/115-HR-5202/)
Report a problem